Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Velneperit

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet

Shionogi · Phase 2 · Completed · Enrollment 842

NCT00748605

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Placebon/rn/rn/rn/r
S-2367 1600 mg q.d. 54 weeksn/rn/rn/rn/r
S-2367 1600 mg q.d. 60 weeksn/rn/rn/rn/r

Not shown

  • Placebo: endpoint not reported
  • S-2367 1600 mg q.d. 54 weeks: endpoint not reported
  • S-2367 1600 mg q.d. 60 weeks: endpoint not reported